Martini-Klinik am UKE GmbH
11
3
5
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Prospective Trial: Acute Myocardial Injury After Radical Prostatectomy
Role: lead
Role of Lymphnode Dissection in Men With Prostate Cancer Treated With Radical Prostatectomy
Role: lead
Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases
Role: lead
Navigation, Outcomes and Quality-of-life in Prostate Cancer Patients Undergoing PSMA-targeted Surgery
Role: lead
Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)
Role: lead
Anatomic Endoscopic Prostate Enucleation and BICEP Classification
Role: collaborator
MICHL-trial: Impact of Peritoneal Bladder Flap in RARP Patients on Lymphoceles
Role: lead
Acupuncture With Press Tack Needles for Perioperative Pain After Open Radical Prostatectomy
Role: lead
Multiparametric Ultrasound-Study for the Detection of Prostate Cancer
Role: lead
Identification of Predictive Biomarkers
Role: lead
Hamburg City Health Study - a German Cohort Study
Role: collaborator
All 11 trials loaded